Citadel Advisors’s Leap Therapeutics LPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.2K | Buy |
+74,931
| New | +$22.2K | ﹤0.01% | 5624 |
|
|
2025
Q1 | – | Sell |
-92,709
| Closed | -$267K | – | 6523 |
|
|
2024
Q4 | $267K | Sell |
92,709
-370,739
| -80% | -$1.07M | ﹤0.01% | 4635 |
|
|
2024
Q3 | $1.19M | Sell |
463,448
-454,658
| -50% | -$1.17M | ﹤0.01% | 2955 |
|
|
2024
Q2 | $1.8M | Buy |
918,106
+206,787
| +29% | +$405K | ﹤0.01% | 2538 |
|
|
2024
Q1 | $1.89M | Buy |
711,319
+28,570
| +4% | +$76K | ﹤0.01% | 2542 |
|
|
2023
Q4 | $2.83M | Buy |
682,749
+38,530
| +6% | +$160K | ﹤0.01% | 2118 |
|
|
2023
Q3 | $889K | Buy |
644,219
+559,615
| +661% | +$772K | ﹤0.01% | 3162 |
|
|
2023
Q2 | $252K | Sell |
84,604
-20,067
| -19% | -$59.7K | ﹤0.01% | 4256 |
|
|
2023
Q1 | $341K | Buy |
104,671
+61,533
| +143% | +$201K | ﹤0.01% | 4191 |
|
|
2022
Q4 | $194K | Buy |
43,138
+28,036
| +186% | +$126K | ﹤0.01% | 4718 |
|
|
2022
Q3 | $133K | Sell |
15,102
-524
| -3% | -$4.62K | ﹤0.01% | 5017 |
|
|
2022
Q2 | $180K | Sell |
15,626
-58,302
| -79% | -$672K | ﹤0.01% | 5045 |
|
|
2022
Q1 | $1.29M | Buy |
73,928
+61,527
| +496% | +$1.08M | ﹤0.01% | 3480 |
|
|
2021
Q4 | $402K | Buy |
12,401
+10,159
| +453% | +$329K | ﹤0.01% | 4817 |
|
|
2021
Q3 | $90K | Sell |
2,242
-980
| -30% | -$39.3K | ﹤0.01% | 5924 |
|
|
2021
Q2 | $53K | Buy |
+3,222
| New | +$53K | ﹤0.01% | 6187 |
|